Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Schleifer Officer, Director	$983.91	250	$245,977.50	398,475	2024-05-15	Filing
Schleifer Officer, Director	$982.66	235	$230,925.10	398,725	2024-05-15	Filing
Schleifer Officer, Director	$981.50	1,081	$1,061,001.50	398,960	2024-05-15	Filing
Schleifer Officer, Director	$980.64	295	$289,288.80	400,041	2024-05-15	Filing
Schleifer Officer, Director	$979.05	7,864	$7,699,249.20	400,336	2024-05-15	Filing
Schleifer Officer, Director	$980.10	2,302	$2,256,190.20	408,200	2024-05-14	Filing
Schleifer Officer, Director	$979.16	22,698	$22,224,973.68	410,502	2024-05-14	Filing
Mccourt Officer	$889.41	250	$222,352.50	12,931	2024-05-01	Filing
Ryan Director	$913.21	1	$913.21	18,082	2024-05-01	Filing
Ryan Director	$912.29	1	$912.29	18,083	2024-05-01	Filing
Ryan Director	$911.39	4	$3,645.56	18,084	2024-05-01	Filing
Ryan Director	$910.47	6	$5,462.82	18,088	2024-05-01	Filing
Ryan Director	$909.49	4	$3,637.96	18,094	2024-05-01	Filing
Ryan Director	$907.54	2	$1,815.08	18,098	2024-05-01	Filing
Ryan Director	$906.26	4	$3,625.04	18,100	2024-05-01	Filing
Ryan Director	$905.50	2	$1,811.00	18,104	2024-05-01	Filing
Ryan Director	$904.80	1	$904.80	18,106	2024-05-01	Filing
Ryan Director	$903.35	1	$903.35	18,107	2024-05-01	Filing
Ryan Director	$902.66	1	$902.66	18,108	2024-05-01	Filing
Ryan Director	$901.41	4	$3,605.64	18,109	2024-05-01	Filing